Last Chance to Register:
- 00Days
- 00Hrs
- 00Mins
- 00Secs
Monday, March 16th, 2026 — Pre-Conference Workshops - EST/EDT (Eastern Daylight, GMT-4)
Identify upcoming legislative and regulatory changes most likely to impact patient support programs and access initiatives
Understand how policy changes are viewed differently by government, industry, and patient advocacy organizations
Develop strategies to anticipate and prepare for policy shifts before they disrupt patient access
- Michael Eging - Executive Director, Rare Access Action Project (RAAP)
- Aaron Winn - Associate Professor, University of Illinois Chicago
- Melissa Horn, MPA - Director of State Legislative Affairs, Arthritis Foundation
- Ulrich Neumann - Director, Access & Policy Research, Johnson & Johnson
Understand how Medicare drug price negotiations reshape patient assistance program design and eligibility requirements
Leverage premium smoothing provisions to enhance affordability while maintaining program sustainability
Adapt patient support services to align with Part D benefit restructuring and out-of-pocket caps
- Corey Ford - Principal, Nuvera, an Inizio Engage Company
Explore how the Big Beautiful Bill (BBB) and new administration priorities transforms the patient support landscape, requiring innovative approaches to ensure continued access
Master the changing Medicaid/Medicare landscape to serve dual-eligible populations
- Michael Eging - Executive Director, Rare Access Action Project (RAAP)
- Alex Meixner - Vice President, State Policy, ALS Association
- Shannon Rohn Deere - Director, Leavitt Partners
Explore the impact of GLOBE and GUARD on patient access and rare disease pipelines
Discuss the rapidly changing MFN policies and their effects on U.S. and global access
Examine strategies to address challenges and opportunities for patients
- Michael Eging - Executive Director, Rare Access Action Project (RAAP)
- Jennifer Snow - Founder, Apteka
- Ashira Vantrees, Esq. - Director Legal Strategy and Advocacy, Aimed Alliance